Citius Pharmaceuticals (CTXR) Stock Price Target 2026

The average analyst price target for Citius Pharmaceuticals is $65, 12224.6% above the current price. Of 4 analysts, 3 rate it Buy and 1 Hold. Targets range from $4 to $150. The latest change came on May 18, 2026, when HC Wainwright & Co. assumed coverage of Citius Pharmaceuticals with a Buy rating and a $4 price target.